Clinical trial
Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
NCT00424762 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2005
- Completion date
- April 30, 2007
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.